PH15637A - Diagnostic method for cancer - Google Patents

Diagnostic method for cancer

Info

Publication number
PH15637A
PH15637A PH23825A PH23825A PH15637A PH 15637 A PH15637 A PH 15637A PH 23825 A PH23825 A PH 23825A PH 23825 A PH23825 A PH 23825A PH 15637 A PH15637 A PH 15637A
Authority
PH
Philippines
Prior art keywords
cancer
diagnostic method
diagnostic
Prior art date
Application number
PH23825A
Other languages
English (en)
Inventor
Stanley T Crooke
Louis Galvan
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of PH15637A publication Critical patent/PH15637A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
PH23825A 1979-04-10 1980-03-28 Diagnostic method for cancer PH15637A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
PH15637A true PH15637A (en) 1983-03-11

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23825A PH15637A (en) 1979-04-10 1980-03-28 Diagnostic method for cancer

Country Status (24)

Country Link
JP (1) JPS55143441A (fr)
KR (1) KR830002502A (fr)
AR (1) AR222700A1 (fr)
AT (1) AT365343B (fr)
AU (1) AU536522B2 (fr)
BE (1) BE882669A (fr)
CH (1) CH644453A5 (fr)
DE (1) DE3013837A1 (fr)
DK (1) DK149980A (fr)
ES (1) ES490396A0 (fr)
FI (1) FI801078A7 (fr)
FR (1) FR2454099A1 (fr)
GB (1) GB2047712B (fr)
GR (1) GR67692B (fr)
HU (1) HU183122B (fr)
IE (1) IE49981B1 (fr)
IL (1) IL59772A (fr)
IT (1) IT1143135B (fr)
LU (1) LU82345A1 (fr)
NL (1) NL8002094A (fr)
NO (1) NO801018L (fr)
PH (1) PH15637A (fr)
SE (1) SE8002602L (fr)
ZA (1) ZA802141B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
FR2454099A1 (fr) 1980-11-07
BE882669A (fr) 1980-10-06
IL59772A0 (en) 1980-06-30
ES8103380A1 (es) 1981-02-16
AU536522B2 (en) 1984-05-10
GR67692B (fr) 1981-09-07
HU183122B (en) 1984-04-28
KR830002502A (ko) 1983-05-30
JPS55143441A (en) 1980-11-08
IE49981B1 (en) 1986-01-22
LU82345A1 (fr) 1980-12-16
ATA195780A (de) 1981-05-15
CH644453A5 (fr) 1984-07-31
ES490396A0 (es) 1981-02-16
IL59772A (en) 1983-05-15
SE8002602L (sv) 1980-12-09
GB2047712A (en) 1980-12-03
IE800693L (en) 1980-10-10
IT1143135B (it) 1986-10-22
AU5719380A (en) 1980-10-16
IT8048370A0 (it) 1980-04-09
FR2454099B1 (fr) 1984-01-27
FI801078A7 (fi) 1981-01-01
AR222700A1 (es) 1981-06-15
AT365343B (de) 1982-01-11
ZA802141B (en) 1981-04-29
NO801018L (no) 1980-10-13
GB2047712B (en) 1983-02-23
NL8002094A (nl) 1980-10-14
DK149980A (da) 1980-10-11
DE3013837A1 (de) 1980-10-30

Similar Documents

Publication Publication Date Title
GB2052909B (en) Apparatus for diagnosing breast cancer
YU11380A (en) Process for obtaining n-benzyl-imidazole
YU65680A (en) Process for obtaining 9-amino-alkylfluorene
YU177880A (en) Process for obtaining acyl-carbamides
YU73183A (en) Process for obtaining 2-amino-3-benzoyl-phenylacetamides
YU116380A (en) Process for obtaining thiazolylidene-oxo-propionitrile
JPS5685332A (en) Urtrasonic diagnosis apparatus
YU13180A (en) Process for obtaining spiro-quinolyl-hydantoin
DE3065060D1 (en) Method for making thiobiscarbamates
YU108580A (en) Process for obtaining alkoxyalkylidene hydrazinopyridazine
YU259680A (en) Process for obtaining acylcarbamides
YU44734B (en) Process for obtaining 3-halogen-cephalosporin iminohalogenids
JPS55129045A (en) Ultrasoniccwave diagnosis method
JPS5666777A (en) Radiation diagnostic apparatus
YU63980A (en) Process for obtaining n-sulfinyl-carbamates
JPS5683336A (en) Urtrasonic diagnosis apparatus
YU276480A (en) Process for obtaining omega-lactams
AU536522B2 (en) Cancer diagnosis method
YU90680A (en) Process for obtaining hydroxyimino-substituted aminoacetonitriles
YU310680A (en) Process for obtaining vanadyl-hydrate
YU43221B (en) Process for obtaining imidazobenzodiazepine
JPS568038A (en) Xxray diagnostic apparatus
JPS5623940A (en) Xxray diagnosis apparatus
YU297780A (en) Process for obtaining glucoso-isomerase
BG29480A1 (en) Method for elimoclavin obtaining